A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

NCT06285643 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: AAV2-GDNF gene therapy
PROCEDURE: control surgery

Sponsor

AskBio Inc

Collaborators

[object Object]